Nimish Shah

Nimish Shah joined Venrock’s New York office in 2013 and focuses on a range of healthcare subsectors including generics, specialty pharmaceuticals, biotechnology and animal health. Most recently, he worked at Citadel and was involved in the firm’s healthcare investments. Prior to Citadel, Nimish was a Research Analyst at Credit Suisse covering the specialty pharma and generics sectors. Nimish began his career as a retail pharmacist and later spent time working in the Medical Affairs department at Novartis. He received his BS in pharmacy with honors from Rutgers College of Pharmacy, MPH from the Mailman School of Public Health at Columbia University, and MBA from Columbia Business School.